[Peritoneal mesothelioma: long survival with intraperitoneal chemotherapy, lanreotide and mucolytics].
Montmayeur
Gaëlle
G
Thivat
Emilie
E
Gimbergues
Pierre
P
Dib
Malek
M
Leheurteur
Marianne
M
Curé
Hervé
H
Chollet
Philippe
P
Durando
Xavier
X
D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005100:Expectorants / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008654:Mesothelioma / Q000188:drug therapy*; D010456:Peptides, Cyclic / Q000627:therapeutic use*; D010534:Peritoneal Neoplasms / Q000188:drug therapy*; D010537:Peritoneum; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017741:Survivors; D013997:Time Factors
D000970:Antineoplastic Agents; D005100:Expectorants; D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin